Genprex

Genprex’s newly licensed type 1 diabetes gene therapy’s potential explained by scientist

Dr. George Gittes, Professor of Surgery at the Children’s Hospital of Pittsburgh, explains how and why he began working on the diabetes gene therapy licensed by Genprex.